Physician profile
Allison Otto
NPI 1376576140
$2,355.71
in general payments reported to CMS, 2019-2025
20 companies · $535 in 2025
The $535 reported for 2025 was more than what 94% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $127 · 2020: $74.18 · 2021: $117 · 2022: $273 · 2023: $458 · 2024: $770 · 2025: $535.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,764.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,763.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ironshore Pharmaceuticals INC. | $672.81 | 2019-2024 | Jornay Pm |
| Supernus Pharmaceuticals, INC. | $487.03 | 2021-2025 | Qelbree, Qelbree |
| Collegium Pharmaceutical, INC. | $172.76 | 2025 | Jornay Pm |
| Sanofi-Aventis U.S. LLC | $132.51 | 2023-2025 | |
| Tris Pharma INC | $129.58 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $120.46 | 2022-2025 | Vaxneuvance, Gardasil 9, Proquad |
| Pfizer INC. | $94.54 | 2023-2025 | |
| Sanofi Pasteur INC. | $89.88 | 2021-2025 | |
| Kaleo, INC. | $84.68 | 2019-2024 | Auvi-Q |
| Corium, LLC | $70.17 | 2022 | |
| Vertical Pharmaceuticals, LLC | $63.16 | 2024-2025 | Relexxii |
| Astrazeneca Pharmaceuticals Lp | $38.44 | 2023-2024 | Flumist Quadrivalent |
| Glaxosmithkline, LLC. | $36.92 | 2020-2022 | |
| Welch Allyn | $34.36 | 2019 | |
| Cranial Technologies, INC | $32.58 | 2022-2023 | Doc Band |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shire North American Group INC | $24.55 | 2019 | |
| Ars Pharmaceuticals Operations, INC. | $22.11 | 2025 | Neffy |
| Hologic Sales and Service, LLC | $19.47 | 2025 | Aptima |
| Ironwood Pharmaceuticals, INC | $16.68 | 2024 | |
| Adlon Therapeutics L.P. | $13.02 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Allison Otto listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.